Diseases, Conditions, Syndromes

Pfizer says tweaked COVID-19 shots boost omicron protection

Pfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is safe and works—just days before regulators debate whether to offer Americans updated booster shots this fall.

Vaccination

COVID shots still work but researchers hunt new improvements

COVID-19 vaccinations are at a critical juncture as companies test whether new approaches like combination shots or nasal drops can keep up with a mutating coronavirus—even though it's not clear if changes are needed.

Diseases, Conditions, Syndromes

Omicron lasts three days less than Delta for boosted: study

People who are vaccinated and have had a booster shot against COVID-19 recover from symptoms from the Omicron variant more than three days earlier than those with the Delta variant, a study said Friday.

page 3 from 40